|
US4444887A
(en)
*
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
JPS57154232A
(en)
*
|
1981-02-18 |
1982-09-24 |
Konishiroku Photo Ind Co Ltd |
Photosensitive silver halide emulsion
|
|
US4714681A
(en)
*
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
|
US4474893A
(en)
*
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
US4647447A
(en)
*
|
1981-07-24 |
1987-03-03 |
Schering Aktiengesellschaft |
Diagnostic media
|
|
US4716111A
(en)
*
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
US4741900A
(en)
*
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
US4816567A
(en)
*
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5807715A
(en)
*
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US4687659A
(en)
*
|
1984-11-13 |
1987-08-18 |
Salutar, Inc. |
Diamide-DTPA-paramagnetic contrast agents for MR imaging
|
|
US4676980A
(en)
*
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US4885363A
(en)
*
|
1987-04-24 |
1989-12-05 |
E. R. Squibb & Sons, Inc. |
1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
|
|
US5057313A
(en)
*
|
1986-02-25 |
1991-10-15 |
The Center For Molecular Medicine And Immunology |
Diagnostic and therapeutic antibody conjugates
|
|
US5225539A
(en)
*
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
*
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5019368A
(en)
*
|
1989-02-23 |
1991-05-28 |
Cancer Biologics, Inc. |
Detection of necrotic malignant tissue and associated therapy
|
|
US5258498A
(en)
*
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US5489425A
(en)
*
|
1987-06-24 |
1996-02-06 |
The Dow Chemical Company |
Functionalized polyamine chelants
|
|
US4994560A
(en)
*
|
1987-06-24 |
1991-02-19 |
The Dow Chemical Company |
Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
|
|
WO1989006692A1
(en)
*
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
US5120525A
(en)
*
|
1988-03-29 |
1992-06-09 |
Immunomedics, Inc. |
Radiolabeled antibody cytotoxic therapy of cancer
|
|
ATE120457T1
(de)
*
|
1988-06-24 |
1995-04-15 |
Dow Chemical Co |
Macrocyclische bifunktionelle chelatbildner, komplexe davon und ihre konjugierten antikörper.
|
|
US5756065A
(en)
*
|
1988-06-24 |
1998-05-26 |
The Dow Chemical Company |
Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
|
|
ZA894792B
(en)
*
|
1988-06-24 |
1991-04-24 |
Dow Chemical Co |
Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
|
|
US5274119A
(en)
*
|
1988-07-01 |
1993-12-28 |
The Dow Chemical Company |
Vicinal diols
|
|
US4925648A
(en)
*
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
|
US5601819A
(en)
*
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
US5223409A
(en)
*
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5696239A
(en)
*
|
1988-10-31 |
1997-12-09 |
The Dow Chemical Company |
Conjugates possessing ortho ligating functionality and complexes thereof
|
|
US5342604A
(en)
*
|
1988-10-31 |
1994-08-30 |
The Dow Chemical Company |
Complexes possessing ortho ligating functionality
|
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5766883A
(en)
*
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
|
US5808003A
(en)
*
|
1989-05-26 |
1998-09-15 |
Perimmune Holdings, Inc. |
Polyaminocarboxylate chelators
|
|
US5413923A
(en)
*
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5780225A
(en)
*
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
ES2087997T3
(es)
*
|
1990-01-12 |
1996-08-01 |
Cell Genesys Inc |
Generacion de anticuerpos xenogenicos.
|
|
US5314995A
(en)
*
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
US5427908A
(en)
*
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
*
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5661016A
(en)
*
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ES2108048T3
(es)
*
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5814318A
(en)
*
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
*
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5698426A
(en)
*
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
US5367080A
(en)
*
|
1990-11-08 |
1994-11-22 |
Sterling Winthrop Inc. |
Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
|
|
DE69129154T2
(de)
*
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
ATE414768T1
(de)
*
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE69214709T2
(de)
*
|
1991-04-26 |
1997-02-20 |
Surface Active Ltd |
Neue Antikörper und Verfahren zu ihrer Verwendung
|
|
US5625425A
(en)
*
|
1991-08-28 |
1997-04-29 |
Kranhouse; Jon |
Diving mask with lenses and method of fabricating the same
|
|
ES2136092T3
(es)
*
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
ATE463573T1
(de)
*
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US5428139A
(en)
*
|
1991-12-10 |
1995-06-27 |
The Dow Chemical Company |
Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
|
|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5733743A
(en)
*
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5505931A
(en)
*
|
1993-03-04 |
1996-04-09 |
The Dow Chemical Company |
Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
|
|
WO1994004670A1
(en)
*
|
1992-08-26 |
1994-03-03 |
President And Fellows Of Harvard College |
Use of the cytokine ip-10 as an anti-tumor agent
|
|
DK0672142T3
(da)
*
|
1992-12-04 |
2001-06-18 |
Medical Res Council |
Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse
|
|
US5441050A
(en)
*
|
1992-12-18 |
1995-08-15 |
Neoprobe Corporation |
Radiation responsive surgical instrument
|
|
US5516637A
(en)
*
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
US5516717A
(en)
*
|
1995-04-19 |
1996-05-14 |
United Microelectronics Corporation |
Method for manufacturing electrostatic discharge devices
|
|
AUPO591797A0
(en)
*
|
1997-03-27 |
1997-04-24 |
Commonwealth Scientific And Industrial Research Organisation |
High avidity polyvalent and polyspecific reagents
|
|
US5972622A
(en)
*
|
1996-02-08 |
1999-10-26 |
Desjardins; Louise |
Method of detecting apoptosis using an anti-human GP46 monoclonal anti-body
|
|
US5935801A
(en)
*
|
1996-03-29 |
1999-08-10 |
Dana-Farber Cancer Institute |
Monoclonal antibody that detects apoptotic antigen
|
|
US5994560A
(en)
*
|
1996-08-29 |
1999-11-30 |
Hoechst Celanese Corp. |
Resolution of racemic mixtures using polymers containing chiral units
|
|
US5916771A
(en)
*
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US5958660A
(en)
*
|
1997-12-31 |
1999-09-28 |
Eastman Kodak Company |
Hydrophilic colloid composition
|
|
US20020052308A1
(en)
*
|
1999-03-12 |
2002-05-02 |
Rosen Craig A. |
Nucleic acids, proteins and antibodies
|
|
CN101643732A
(zh)
*
|
2000-04-04 |
2010-02-10 |
罗切斯特大学 |
在乳腺癌和膀胱癌中差异表达的基因及编码的多肽
|
|
AU5532601A
(en)
*
|
2000-04-12 |
2001-10-30 |
Univ Rochester |
Targeted vaccine delivery systems
|
|
US20050196755A1
(en)
*
|
2000-11-17 |
2005-09-08 |
Maurice Zauderer |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
JP4368196B2
(ja)
*
|
2000-11-17 |
2009-11-18 |
ユニバーシティー オブ ロチェスター |
真核細胞において免疫グロブリン分子を製造および同定するインビトロにおける方法
|
|
PL374495A1
(en)
*
|
2001-10-15 |
2005-10-31 |
Immunomedics, Inc. |
Direct targeting binding proteins
|
|
WO2003104428A2
(en)
*
|
2002-01-21 |
2003-12-18 |
Vaccinex, Inc. |
Gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
|
WO2005055936A2
(en)
*
|
2003-12-04 |
2005-06-23 |
Vaccinex, Inc. |
Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
|